AI Analysis AI Analysis of CPHRF
AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment
Trading Strategy
PDF

Green day on Monday for Cipher Pharmaceuticals Inc.
(Updated on Nov 17, 2025)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Nov 12, 2025 Loss -0.96%

The Cipher Pharmaceuticals Inc. stock price gained 2.27% on the last trading day (Monday, 17th Nov 2025), rising from $9.33 to $9.54. During the last trading day the stock fluctuated 2.73% from a day low at $9.54 to a day high of $9.80. The price has fallen in 6 of the last 10 days and is down by -8.82% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 6 thousand more shares were traded than the day before. In total, 6 thousand shares were bought and sold for approximately $61.21 thousand.

The stock lies in the lower of a wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $9.30 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -13.01% during the next 3 months and, with a 90% probability hold a price between $8.09 and $9.81 at the end of this 3-month period.

CPHRF Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, November 14, 2025, and so far it has risen 2.27%. Further rise is indicated until a new top pivot has been found. Cipher Pharmaceuticals Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Cipher Pharmaceuticals Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $9.56 and $10.39. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Cipher Pharmaceuticals Inc. stock

Cipher Pharmaceuticals Inc. finds support from accumulated volume at $9.45 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.260 between high and low, or 2.73%. For the last week, the stock has had daily average volatility of 2.24%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CPHRF) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Cipher Pharmaceuticals Inc. to open at $9.63, and during the day (based on 14 day Average True Range), to move between $9.38 and $9.70, which gives a possible trading interval of +/-$0.329 (+/-3.51%) up or down from last closing price. If Cipher Pharmaceuticals Inc. takes out the full calculated possible swing range there will be an estimated 3.51% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $9.60 (0.63%) than the support at $9.45 (0.96%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Cipher Pharmaceuticals Inc. stock A Buy?

Cipher Pharmaceuticals Inc. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -1.166 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $9.63 ( 0.91%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk

CPHRF Performance

Trading levels for CPHRF

Full Access. No Commitment. 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 5 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 9.89 3.63%
R2 9.79 2.59%
R1 9.73 1.95%
Price 9.54
S1 9.53 -0.133%
S2 9.47 -0.776%
S3 9.37 -1.82%

Accumulated Volume Support & Resistance Levels

Level Price
R3 11.65 22.12%
R2 9.70 1.68%
R1 9.60 0.629%
Price 9.54
S1 9.45 -0.96%
S2 9.33 -2.22%
S3 0 -

FAQ

What is the symbol for Cipher Pharmaceuticals Inc. Stock and on which exchange is it traded?
The symbol for Cipher Pharmaceuticals Inc. is CPHRF and it is traded on the OTCMKTS (OTC Markets Group).

Should I buy or sell Cipher Pharmaceuticals Inc. Stock?
Cipher Pharmaceuticals Inc. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Cipher Pharmaceuticals Inc. Stock?
Cipher Pharmaceuticals Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Cipher Pharmaceuticals Inc. Stock.

What's the current price of Cipher Pharmaceuticals Inc. Stock?
As of the end of day on the Nov 17, 2025, the price of an Cipher Pharmaceuticals Inc. (CPHRF) share was $9.54.

What is the 52-week high and low for Cipher Pharmaceuticals Inc. Stock?
The 52-week high for Cipher Pharmaceuticals Inc. Stock is $12.48 and the 52-week low is $6.63.

What is the market capitalization of Cipher Pharmaceuticals Inc. Stock?
As of the Nov 17, 2025, the market capitalization of Cipher Pharmaceuticals Inc. is 242.026M.
Click to get the best stock tips daily for free!
ABOUT CIPHER PHARMACEUTICALS INC.
Cipher Pharmaceuticals
Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. Its commercial products include Epuris (CIP-ISOTRETINOIN), a formulation of the active ingredient isotretinoin for use in the treatment of severe acne; Ozenoxacin to treat adult and paediatric patients with impetigo; Actikerall, which is indicated for the treatment of palpable or moderately thick hyperkeratotic actinic keratosis; Vaniqa, a prescription cream tha...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE